Pharmacology of tyrosine kinase inhibitors in chronic myeloid leukemia; a clinician’s perspective
Crossref DOI link: https://doi.org/10.1007/s40199-019-00321-z
Published Online: 2020-01-03
Published Print: 2020-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Pushpam, Deepam
Bakhshi, Sameer
Text and Data Mining valid from 2020-01-03
Version of Record valid from 2020-01-03
Article History
Received: 29 March 2019
Accepted: 17 December 2019
First Online: 3 January 2020
Compliance with ethical standards
:
: The authors declare that they have no conflict of interest.